| Literature DB >> 9667605 |
H T Verzijl1, B G van Engelen, J A Luyten, G C Steenbergen, L P van den Heuvel, H J ter Laak, G W Padberg, R A Wevers.
Abstract
Two types of myoadenylate deaminase (MAD) deficiency have been described, primary or inherited, and secondary or acquired MAD deficiency. In this study, we investigated whether secondary MAD deficiency is indeed acquired or merely coincidental. We demonstrated the same underlying molecular defect, a C34T transition, in both types of deficiency. Furthermore, the same frequency of the mutant MAD allele was found in the general population as in patients with neuromuscular complaints. We therefore conclude that in the Dutch population, secondary MAD deficiency is merely a "coincidental" finding, and that MAD deficiency is a harmless genetic variant.Entities:
Mesh:
Substances:
Year: 1998 PMID: 9667605 DOI: 10.1002/ana.410440124
Source DB: PubMed Journal: Ann Neurol ISSN: 0364-5134 Impact factor: 10.422